Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Finished Goods (2016 - 2025)

STRATA Skin Sciences' Finished Goods history spans 13 years, with the latest figure at $171000.0 for Q3 2025.

  • For Q3 2025, Finished Goods fell 50.29% year-over-year to $171000.0; the TTM value through Sep 2025 reached $171000.0, down 50.29%, while the annual FY2024 figure was $205000.0, 57.38% down from the prior year.
  • Finished Goods for Q3 2025 was $171000.0 at STRATA Skin Sciences, up from $63000.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $877000.0 in Q1 2022 and bottomed at $63000.0 in Q2 2025.
  • The 5-year median for Finished Goods is $288000.0 (2021), against an average of $313105.3.
  • The largest annual shift saw Finished Goods soared 272.87% in 2023 before it tumbled 80.85% in 2025.
  • A 5-year view of Finished Goods shows it stood at $288000.0 in 2021, then tumbled by 55.21% to $129000.0 in 2022, then skyrocketed by 272.87% to $481000.0 in 2023, then plummeted by 57.38% to $205000.0 in 2024, then fell by 16.59% to $171000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Finished Goods are $171000.0 (Q3 2025), $63000.0 (Q2 2025), and $159000.0 (Q1 2025).